ETFs & MarketsPremiumQuantumScape Targets Double Eagle Line Output by H2 2026, Lowers 2026 CapEx to $27M-$37M
QuantumScape has unveiled plans to significantly scale its Eagle Line cell production, targeting a twofold increase in output by the second half of 2026. This ambitious production target is coupled with a notable reduction in its 2026 capital expenditure guidance, now projected between $27 million and $37 million.
Published 2 hours ago
Read more →